Dina Hany
Affiliations: | University of Geneva, Geneva, Switzerland |
Area:
Cell Biology, Cancer, Breast cancer, estrogen receptor, endocrine therapy, tamoxifen resistanceGoogle:
"Dina Hany"Parents
Sign in to add mentor| Didier Picard | grad student | 2017-2022 | University of Geneva (DevTree) | |
| (Ph.D. student) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Maiti S, Bhattacharya K, Wider D, et al. (2023) Hsf1 and the molecular chaperone Hsp90 support a 'rewiring stress response' leading to an adaptive cell size increase in chronic stress. Elife. 12 |
| Hany D, Zoetemelk M, Bhattacharya K, et al. (2023) Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and Molecular Life Sciences : Cmls. 80: 80 |
| Bhattacharya K, Maiti S, Zahoran S, et al. (2022) Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life. Nature Communications. 13: 6271 |
| Vafeiadou V, Hany D, Picard D.. (2022) Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer Cancers. 14: 954 |